Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland.
Agora Cancer Research Center, Lausanne, Switzerland.
Nat Cancer. 2024 Jun;5(6):827-843. doi: 10.1038/s43018-024-00780-7. Epub 2024 Jun 25.
Research into the mechanisms and manifestations of solid tumor vascularization was launched more than 50 years ago with the proposition and experimental demonstrations that angiogenesis is instrumental for tumor growth and was, therefore, a promising therapeutic target. The biological knowledge and therapeutic insights forthcoming have been remarkable, punctuated by new concepts, many of which were not foreseen in the early decades. This article presents a perspective on tumor vascularization and its therapeutic targeting but does not portray a historical timeline. Rather, we highlight eight conceptual milestones, integrating initial discoveries and recent progress and posing open questions for the future.
对实体瘤血管生成的机制和表现的研究始于 50 多年前,当时提出并通过实验证明了血管生成对于肿瘤生长至关重要,因此是一个有前途的治疗靶点。随之而来的生物学知识和治疗见解引人注目,出现了许多新概念,其中许多在最初几十年都没有预见。本文介绍了肿瘤血管生成及其治疗靶点的观点,但没有描绘历史时间线。相反,我们强调了八个概念性的里程碑,整合了最初的发现和最近的进展,并为未来提出了一些悬而未决的问题。